MyBlueDotsFrenelle Pharma Officially Launches: CEO Missling Attends JPM 2025 Representing Frenelle’s Portfolio MyBlueDots2 weeks ago01 mins PLYMOUTH, Minn.–(BUSINESS WIRE)–Our proprietary technology enables precise, sustained delivery of medications, reducing dosing frequency while enhancing efficacy & patient compliance Go to Source Author: Post navigation Previous: AI can enhance cervical cancer detection with medical image recognitionNext: China Pharmaceutical Regulatory Affairs Training Course: How to Gain and Maintain a Successful Marketing Authorisation in the PRC, Including Hong Kong, Macau and Taiwan (ONLINE EVENT: April 8-9, 2025) – ResearchAndMarkets.com
People who are autistic and transgender/gender diverse have poorer health and health care, study finds MyBlueDots17 hours ago 0
Digital therapeutics: Exploring the road to commercialization across international markets MyBlueDots21 hours ago 0